Zeta Corporation was founded in 2003 in the State of California, USA.

We specialize in providing high-quality, popular IVD antibodies for pathologic diagnosis, guiding cancer treatment, and predicting cancer prognosis.

Many of our antibodies are Monospecific Mouse Monoclonal Antibodies.

We also provide IVD antibodies for cancer targeted therapy and immunotherapy due to gene mutations, chromosomal translocations or gene amplification.  All of our antibodies work on formalin-fixed and paraffin-embedded (FFPE) tissue sections.

An ISO 13485:2016 and FDA certified biomedical company, all of our antibody clones are scientifically and carefully selected to fit the needs of clinical immunohistochemical laboratories.  Our primary antibodies are manufactured in GMP facilities and purified by affinity chromatography with >99% purity.